Two lawsuits vs. Tempus raise questions about privacy of germline data in cancer RWE“Deidentified” ≠ “deidentifiable” February 27, 2026Vol.52 No.08By Paul Goldberg
Black History MonthPodcast Joni Nelson tells us how her background led her to pursue research that meets the needs of the community“I’m standing on the shoulders of giants” February 27, 2026Vol.52 No.08By Joni D. Nelson, Robert A. Winn and Preston Willett
After a year, Stephenson institute sees a broader role in funding pancreatic cancer research, fostering collaborations“We are not just funding research. We are building a trusted community.” February 27, 2026Vol.52 No.08By Jacquelyn Cobb
Guest Editorial When radiology fails to fix clinical trial imaging workflow at sites…What most think, why it’s wrong, and what cancer centers really need February 27, 2026Vol.52 No.08By Jeff Sorenson
Cancer Policy USPSTF under threat of elimination, former members warn February 27, 2026Vol.52 No.08By Claire Marie Porter
Cancer Policy Trump administration announces “major crackdown” on healthcare fraud February 27, 2026Vol.52 No.08By Claire Marie Porter
Cancer Policy FDA issues draft guidance on accelerating development of individualized therapies for ultra-rare diseases February 27, 2026Vol.52 No.08
In Brief Lou Weiner to step down as director of Georgetown’s Lombardi CCC after 18 years February 27, 2026Vol.52 No.08
In Brief David Weinberg named VP, associate director for cancer screening & prevention at Fox Chase February 27, 2026Vol.52 No.08
